BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 19996742)

  • 21. Heparin-induced thrombocytopenia: a frequent complication after cardiac surgery.
    Pouplard C; Regina S; May MA; Gruel Y
    Arch Mal Coeur Vaiss; 2007; 100(6-7):563-8. PubMed ID: 17893639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Practical viewpoints on the diagnosis and management of heparin-induced thrombocytopenia.
    Lassila R; Antovic JP; Armstrong E; Baghaei F; Dalsgaard-Nielsen J; Hillarp A; Holme PA; Holmström M; Johnsson H; Joutsi-Korhonen L; Sandset PM
    Semin Thromb Hemost; 2011 Apr; 37(3):328-36. PubMed ID: 21455867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasmapheresis and heparin reexposure as a management strategy for cardiac surgical patients with heparin-induced thrombocytopenia.
    Welsby IJ; Um J; Milano CA; Ortel TL; Arepally G
    Anesth Analg; 2010 Jan; 110(1):30-5. PubMed ID: 19933539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recognition of heparin-induced thrombocytopenia and initiation of argatroban therapy after cardiothoracic surgery in the intensive care unit.
    Demma LJ; Paciullo CA; Levy JH
    J Thorac Cardiovasc Surg; 2012 May; 143(5):1213-8. PubMed ID: 22329977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on heparin-induced thrombocytopenia and cardiovascular interventions.
    Spiess BD
    Semin Hematol; 2005 Jul; 42(3 Suppl 3):S22-7. PubMed ID: 16105555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heparin-induced thrombocytopenia: diagnosis and management.
    Liebman HA
    Vascular; 2008; 16 Suppl 1():S71-6. PubMed ID: 18544310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bivalirudin for anticoagulation in mechanical aortic valve replacement and heparin-induced thrombocytopenia.
    Klein M; Tomer A; Swartz A; Koyffman L; Weksler N
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):331-3. PubMed ID: 16651880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Heparin-induced thrombocytopenia].
    Christoffersen C; Lethagen S; Gøtze JP
    Ugeskr Laeger; 2009 Feb; 171(8):612-5. PubMed ID: 19284907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.
    Jeske WP; Walenga JM
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1171-80. PubMed ID: 12211410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Developing an algorithm for treating heparin-induced thrombocytopenia.
    McIntosh BA
    Clin Adv Hematol Oncol; 2004 Apr; 2(4):216-22. PubMed ID: 16163184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparin-induced thrombocytopenia, a prothrombotic disease.
    Levy JH; Hursting MJ
    Hematol Oncol Clin North Am; 2007 Feb; 21(1):65-88. PubMed ID: 17258119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonin release assay (SRA)-negative HIT, a newly recognized entity: Implications for diagnosis and management.
    Pandya KA; Johnson EG; Davis GA; Padmanabhan A
    Thromb Res; 2018 Dec; 172():169-171. PubMed ID: 30419472
    [No Abstract]   [Full Text] [Related]  

  • 33. Heparin-induced thrombocytopenia: a general review.
    Swanson JM
    J Infus Nurs; 2007; 30(4):232-40. PubMed ID: 17667079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An anesthesia provider's perspective of heparin-induced thrombocytopenia.
    Woodyard DN
    AANA J; 2005 Apr; 73(2):115-9. PubMed ID: 15835831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical challenge: heparin-induced thrombocytopenia type II (HIT II) or pseudo-HIT in a patient with antiphospholipid syndrome.
    Perunicic J; Antonijevic NM; Miljic P; Djordjevic V; Mikovic D; Kovac M; Djokic M; Mrdovic I; Nikolic A; Vasiljevic Z
    J Thromb Thrombolysis; 2008 Oct; 26(2):142-6. PubMed ID: 17828468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection and significance of heparin-platelet factor 4 antibodies.
    Francis JL
    Semin Hematol; 2005 Jul; 42(3 Suppl 3):S9-14. PubMed ID: 16105558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heparin-induced thrombocytopenia.
    Szokol JW
    Semin Cardiothorac Vasc Anesth; 2010 Mar; 14(1):73-4. PubMed ID: 20472634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of anticoagulation in patients with subacute heparin-induced thrombocytopenia scheduled for heart transplantation.
    Selleng S; Haneya A; Hirt S; Selleng K; Schmid C; Greinacher A
    Blood; 2008 Nov; 112(10):4024-7. PubMed ID: 18791163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The identification and management of heparin-induced thrombocytopenia in the vascular patient.
    LaMuraglia GM; Houbballah R; Laposata M
    J Vasc Surg; 2012 Feb; 55(2):562-70. PubMed ID: 22188737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heparin induced thrombocytopenia: pathogenetic, clinical, diagnostic and therapeutic aspects.
    Castelli R; Cassinerio E; Cappellini MD; Porro F; Graziadei G; Fabris F
    Cardiovasc Hematol Disord Drug Targets; 2007 Sep; 7(3):153-62. PubMed ID: 17896955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.